Insider Transactions in Q4 2020 at Theravance Biopharma, Inc. (TBPH)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2020
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Open market or private sale
|
Direct |
7,500
-5.71%
|
$142,500
$19.47 P/Share
|
|
Dec 03
2020
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Open market or private sale
|
Direct |
4,246
-1.31%
|
$76,428
$18.0 P/Share
|
|
Nov 20
2020
|
Ann Brady PRESIDENT, TBIL |
SELL
Payment of exercise price or tax liability
|
Direct |
2,292
-2.28%
|
$38,964
$17.21 P/Share
|
|
Nov 20
2020
|
Richard A Graham SVP, RESEARCH & DEVELOPMENT |
SELL
Payment of exercise price or tax liability
|
Direct |
3,876
-2.87%
|
$65,892
$17.21 P/Share
|
|
Nov 20
2020
|
Brett K Haumann Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,639
-1.64%
|
$78,863
$17.21 P/Share
|
|
Nov 20
2020
|
Frank Pasqualone SVP, CHIEF BUSINESS OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,214
-1.04%
|
$71,638
$17.21 P/Share
|
|
Nov 20
2020
|
Kenneth R Pitzer SVP, PROD STRAT & COMM PLNG |
SELL
Payment of exercise price or tax liability
|
Direct |
4,807
-1.41%
|
$81,719
$17.21 P/Share
|
|
Nov 20
2020
|
Vijay Sabesan SVP, TECHNICAL OPERATIONS |
SELL
Payment of exercise price or tax liability
|
Direct |
3,798
-1.93%
|
$64,566
$17.21 P/Share
|
|
Nov 20
2020
|
Bradford J Shafer EVP, Gen. Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
4,807
-1.87%
|
$81,719
$17.21 P/Share
|
|
Nov 20
2020
|
Rick E Winningham CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
13,946
-1.08%
|
$237,082
$17.21 P/Share
|
|
Nov 20
2020
|
Philip D Worboys SVP, RESEARCH & TRANSL SCIENCE |
SELL
Payment of exercise price or tax liability
|
Direct |
4,807
-1.46%
|
$81,719
$17.21 P/Share
|